Literature DB >> 17437311

Total synthesis of the potent antitumor macrolides pladienolide B and D.

Regina M Kanada1, Daisuke Itoh, Mitsuo Nagai, Jun Niijima, Naoki Asai, Yoshiharu Mizui, Shinya Abe, Yoshihiko Kotake.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17437311     DOI： 10.1002/anie.200604997

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN： 1433-7851            Impact factor:   15.336


× No keyword cloud information.
  19 in total

1.  Design and Synthesis of 1,2-Deoxy-pyranose Derivatives of Spliceostatin A toward Prostate Cancer Treatment.

Authors:  Yusuke Yoshikawa; Airi Ishibashi; Tsunayoshi Takehara; Takeyuki Suzuki; Kenichi Murai; Yasufumi Kaneda; Keisuke Nimura; Mitsuhiro Arisawa
Journal:  ACS Med Chem Lett       Date:  2020-05-01       Impact factor: 4.345

2.  A synthetic entry to pladienolide B and FD-895.

Authors:  Alexander L Mandel; Brian D Jones; James J La Clair; Michael D Burkart
Journal:  Bioorg Med Chem Lett       Date:  2007-07-07       Impact factor: 2.823

3.  Design, synthesis and initial biological evaluation of a novel pladienolide analog scaffold.

Authors:  Mahesh Kumar Gundluru; Alan Pourpak; Xiaoli Cui; Stephan W Morris; Thomas R Webb
Journal:  Medchemcomm       Date:  2011-01-01       Impact factor: 3.597

Review 4.  A Challenging Pie to Splice: Drugging the Spliceosome.

Authors:  Brian León; Manoj K Kashyap; Warren C Chan; Kelsey A Krug; Januario E Castro; James J La Clair; Michael D Burkart
Journal:  Angew Chem Int Ed Engl       Date:  2017-08-15       Impact factor: 15.336

Review 5.  Modulating splicing with small molecular inhibitors of the spliceosome.

Authors:  Kerstin A Effenberger; Veronica K Urabe; Melissa S Jurica
Journal:  Wiley Interdiscip Rev RNA       Date:  2016-07-21       Impact factor: 9.957

6.  Structure of FD-895 revealed through total synthesis.

Authors:  Reymundo Villa; Alexander L Mandel; Brian D Jones; James J La Clair; Michael D Burkart
Journal:  Org Lett       Date:  2012-10-16       Impact factor: 6.005

Review 7.  The development and application of small molecule modulators of SF3b as therapeutic agents for cancer.

Authors:  Thomas R Webb; Amanda S Joyner; Philip M Potter
Journal:  Drug Discov Today       Date:  2012-08-03       Impact factor: 7.851

8.  Evolution of a Unified Strategy for Complex Sesterterpenoids: Progress toward Astellatol and the Total Synthesis of (-)-Nitidasin.

Authors:  Daniel T Hog; Florian M E Huber; Gonzalo Jiménez-Osés; Peter Mayer; Kendall N Houk; Dirk Trauner
Journal:  Chemistry       Date:  2015-08-20       Impact factor: 5.236

9.  Stabilized cyclopropane analogs of the splicing inhibitor FD-895.

Authors:  Reymundo Villa; Manoj Kumar Kashyap; Deepak Kumar; Thomas J Kipps; Januario E Castro; James J La Clair; Michael D Burkart
Journal:  J Med Chem       Date:  2013-08-21       Impact factor: 7.446

10.  Meayamycin inhibits pre-messenger RNA splicing and exhibits picomolar activity against multidrug-resistant cells.

Authors:  Brian J Albert; Peter A McPherson; Kristine O'Brien; Nancy L Czaicki; Vincent Destefino; Sami Osman; Miaosheng Li; Billy W Day; Paula J Grabowski; Melissa J Moore; Andreas Vogt; Kazunori Koide
Journal:  Mol Cancer Ther       Date:  2009-08-11       Impact factor: 6.261
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.